Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A401UY | ISIN: US36151G6008 | Ticker-Symbol: 12Q0
Lang & Schwarz
28.06.25 | 09:00
1,475 Euro
-100,00 % -1,475
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INTELLIGENT BIO SOLUTIONS INC Chart 1 Jahr
5-Tage-Chart
INTELLIGENT BIO SOLUTIONS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,49009:00

Aktuelle News zur INTELLIGENT BIO SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiIntelligent Bio Solutions expands drug screening in Scandinavia1
MiIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia4
18.06.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Launches In-House Fingerprint Drug Testing Across 20+ Sites for Major Australian Waste Operator, Accelerating APAC Expansion6
18.06.EXCLUSIVE: Intelligent Bio's Fingerprint Drug Testing Gains Momentum With New Australian Rollout5
16.06.INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach3
11.06.INBS fingerprint drug screening system deployed in over 50 US locations3
INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln
11.06.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing108SMARTOX has deployed over 50 of INBS' Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues...
► Artikel lesen
11.06.EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks FDA Clearance For Fingerprint Drug Testing1
30.05.INTELLIGENT BIO SOLUTIONS INC. - S-8, Securities to be offered to employees in employee benefit plans14
19.05.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment8
15.05.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing4
13.05.INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report1
13.05.Intelligent Bio Solutions GAAP EPS of -$0.44, revenue of $0.73M1
13.05.INTELLIGENT BIO SOLUTIONS INC. - 10-Q, Quarterly Report4
13.05.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements67720% sequential quarterly revenue growth and 91% year-over-year quarterly gross profit growth Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the...
► Artikel lesen
13.05.EXCLUSIVE: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%4
07.05.Ex-INBS boss Michael Fingleton was 'nodding through' top-up loans to certain clients, High Court told4
06.05.Civil case against former INBS boss Michael Fingleton begins in High Court3
27.03.Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win5
27.03.Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra252INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK...
► Artikel lesen
Weiter >>
64 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,5